About BreatheSuite
BreatheSuite is a company based in St. John's (Canada) founded in 2018. BreatheSuite has raised $1.49 million across 2 funding rounds from investors including Killick Capital and Pelorus Venture. BreatheSuite offers products and services including BreatheSuite Program and Welcome Kit. BreatheSuite operates in a competitive market with competitors including Wellth, Cureatr, Phil, Proteus Digital Health and Spencer Health Solutions, among others.
- Headquarter St. John's, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Breathesuite Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.49 M (USD)
in 2 rounds
-
Latest Funding Round
$943.77 K (USD), Seed
Jan 14, 2021
-
Investors
Killick Capital
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BreatheSuite
BreatheSuite offers a comprehensive portfolio of products and services, including BreatheSuite Program and Welcome Kit.
At-home program for lung wellness with exercises and therapist support.
Kit providing tools like pulse oximeter for home respiratory monitoring.
People of BreatheSuite
Unlock access to complete
Funding Insights of BreatheSuite
BreatheSuite has successfully raised a total of $1.49M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $943.77 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $943,771
-
First Round
First Round
(24 Oct 2019)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Seed - BreatheSuite | Valuation | Pelorus Venture | |
| Oct, 2019 | Amount | Seed - BreatheSuite | Valuation | Pelorus Venture |
|
Investors in BreatheSuite
BreatheSuite has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Killick Capital and Pelorus Venture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Killick Capital is engaged in private equity investments in Canada.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by BreatheSuite
Financial Statements - BreatheSuite
Breathesuite Comparisons
Competitors of BreatheSuite
BreatheSuite operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wellth, Cureatr, Phil, Proteus Digital Health and Spencer Health Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provides AI and cloud-based platform for doctors for patient engagement and care
|
|
| domain | founded_year | HQ Location |
Cloud-based medication management software is provided for healthcare providers.
|
|
| domain | founded_year | HQ Location |
Prescription drugs refill management solutions
|
|
| domain | founded_year | HQ Location |
Cloud-based medication adherence monitoring is provided for healthcare providers.
|
|
| domain | founded_year | HQ Location |
Devices and apps for medication adherence are provided.
|
|
| domain | founded_year | HQ Location |
Medication management systems are supplied to healthcare providers and pharmacies.
|
Frequently Asked Questions about BreatheSuite
BreatheSuite was founded in 2018 and raised its 1st funding round 1 year after it was founded.
BreatheSuite is headquartered in St. John's, Canada. It is registered at St. John's, Newfoundland And Labrador, Canada.
BreatheSuite is a funded company, having raised a total of $1.49M across 2 funding rounds to date. The company's 1st funding round was a Seed of $550K, raised on Oct 24, 2019.
BreatheSuite was founded in 2018 in St. Johns, Canada, within the health technology sector focused on respiratory care. An integrated inhaler device is developed, linking via Bluetooth to a mobile app that monitors medication intake, dosage, and inhalation technique. Real-time training and adherence reminders are delivered through the app. Data sharing is enabled with physicians, care teams, and family members to support ongoing management of asthma and COPD.
BreatheSuite's top competitors include Wellth, Phil and Capsa Healthcare.
BreatheSuite offers BreatheSuite Program and Welcome Kit.
BreatheSuite has 2 investors. Key investors include Killick Capital, and Pelorus Venture.